The decline in bone mass with age leads to osteoporosis, a major cause of dissability and morbidity. The basic defect seems to be associated with the unavailability of calcifiable collagen matrix. We have observed that transplantation of syngeneic embryonic cells to very old rats within a osteoinductive resorbable chamber generates bone. Simultaneously we have established significant biochemical and histological differences between true bone formation and dystrophic calcification. We shall continue to investigate the metabolic activities of committed osteogenic and of osteoprogenic cells during the various stages of bone induction. What dictates the presence or absence of cartilage and what is its role in this system? We shall quantitate chondrogenesis using specific markers (collagen types II, 1 alpha, 2 alpha, 3 alpha, IX, X and 35S-labelled proteoglycans). We shall relate these to bone formation for measuring type I collagen and BGP. We shall search for ways to distinguish type I collagen produced by mesenchymal cells and bone cells (i.e. hydroxylysine content of the alpha 2 chain and patterns of glycosylation). We will look for new ways to grow bone cells in vitro, so that they generate a calcifiable matrix, and continue to study the mechanisms of dystrophic calcification and develop animal models to evaluate our potential to enhance bone formation.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37AG002577-10
Application #
3479999
Study Section
Orthopedics and Musculoskeletal Study Section (ORTH)
Project Start
1987-12-01
Project End
1992-11-30
Budget Start
1991-12-15
Budget End
1992-11-30
Support Year
10
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Southern California
Department
Type
Schools of Medicine
DUNS #
041544081
City
Los Angeles
State
CA
Country
United States
Zip Code
90089
Li, Feng; Zhang, Le; Craddock, Jeffrey et al. (2008) Aging and dietary restriction effects on ubiquitination, sumoylation, and the proteasome in the heart. Mech Ageing Dev 129:515-21
Zhang, Le; Li, Feng; Dimayuga, Edgardo et al. (2007) Effects of aging and dietary restriction on ubiquitination, sumoylation, and the proteasome in the spleen. FEBS Lett 581:5543-7
Andrades, J A; Santamaria, J A; Wu, L T et al. (2001) Production of a recombinant human basic fibroblast growth factor with a collagen binding domain. Protoplasma 218:95-103
Andrades, J A; Wu, L T; Hall, F L et al. (2001) Engineering, expression, and renaturation of a collagen-targeted human bFGF fusion protein. Growth Factors 18:261-75
Andrades, J A; Han, B; Becerra, J et al. (1999) A recombinant human TGF-beta1 fusion protein with collagen-binding domain promotes migration, growth, and differentiation of bone marrow mesenchymal cells. Exp Cell Res 250:485-98
Gade, P V; Andrades, J A; Nimni, M E et al. (1997) Nitric oxide mediates hyperglycemia-induced defective migration in cultured endothelial cells. J Vasc Surg 26:319-26
Gordon, E M; Skotzko, M; Kundu, R K et al. (1997) Capture and expansion of bone marrow-derived mesenchymal progenitor cells with a transforming growth factor-beta1-von Willebrand's factor fusion protein for retrovirus-mediated delivery of coagulation factor IX. Hum Gene Ther 8:1385-94
Han, B; Hall, F L; Nimni, M E (1997) Refolding of a recombinant collagen-targeted TGF-beta2 fusion protein expressed in Escherichia coli. Protein Expr Purif 11:169-78
Becerra, J; Andrades, J A; Ertl, D C et al. (1996) Demineralized bone matrix mediates differentiation of bone marrow stromal cells in vitro: effect of age of cell donor. J Bone Miner Res 11:1703-14
Andrades, J A; Nimni, M E; Han, B et al. (1996) Type I collagen combined with a recombinant TGF-beta serves as a scaffold for mesenchymal stem cells. Int J Dev Biol Suppl 1:107S-108S

Showing the most recent 10 out of 22 publications